1Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cancer worldwide: a meta-analysis[ J]. Br J cancer, 2003, 88(2): 63-73.
2Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the international agency for research on cancer HPV prevalence surveys : a pooled analysis[ J]. Lancet, 2005,366 : 991-998.
3Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India[J]. N Engl J Med, 2009, 360 : 1385-1394.
4Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papiUomavirus Infection as a predictor of cervical Intraepithelial neoplasia[ J]. JAMA, 2001,286: 3106-3114.
6Hummer M, Schiffman M, Castle PE, et al. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous intraepithelial lesion[ J]. J Infect Dis, 2007,95:1582-1589.
7Aerssens A, Claeys P, Garcia A, et al. Natural history and clearance of HPV after treatment of precancerous cervical lesions [ J]. Histopathology,2008,52:381-386.
8Soutter WP, de Barros Lopes A, Fcetcher A, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia [J]. Lancet,1997, 349(9057):978-980.
9Elfgren K, Jacobs M, Walboomers JM, et al. Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia [ J ]. Obstet Gynecol, 2002,100:965-971.
10Debarge HV, Collinet P, Vinatier D, et al. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions[ J]. Gynecol Oneol, 2003,90(3) : 587-592.
